AGP Executive Report
Last update: 8 hours agoMicroplastics Monitoring: Scientists from 21 African countries met in Accra to harmonise coastal microplastics monitoring protocols using nuclear and isotopic techniques, aiming for comparable data and stronger marine pollution policies—Mauritius included. Ebola Drug Trial Prep: Mauritius-headquartered Xylomed Pharmaceuticals says it is preparing a double-blind, randomised Phase 3B clinical trial of an experimental Ebola therapeutic in DRC, Uganda and South Sudan. HIV Treatment Snapshot (Nigeria): New figures show about 1.70 million Nigerians on HIV treatment as of 30 June 2026, highlighting ongoing need for steady access to care and medicines. Fertiliser Trade Disruption: WTO data links Persian Gulf conflict disruptions to urea and phosphate fertilizer shortages, raising risks of higher food prices and pressure on farm yields. One Health Biodiversity Link: LifeWatch BEeS 2026 conference in Plovdiv spotlights the One Health approach, linking healthy ecosystems to human wellbeing. Local Governance/Health Context: Commentary argues Africa’s health outcomes hinge on governance and sovereignty, not just donor aid cycles.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
